Table of Contents
Chapter 1. Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Phase
1.1.2 Product and Service
1.1.3 End Use
1.1.4 Therapeutic Use
1.1.5 Regional Scope
1.1.6 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Data for Primary Interviews in North America
1.3.5.2 Data for Primary Interviews in Europe
1.3.5.3 Data for Primary Interviews in APAC
1.3.5.4 Data for Primary Interviews in Latin America
1.3.5.5 Data for Primary Interviews in Middle East & Africa
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective 1
1.8.2 Objective 2
Chapter 2. Executive Summary
2.1 Market Outlook
Chapter 3. Clinical Trial Supplies Market Variables, Trends, & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.1.1 Expansion of Clinical Trial Sites
3.1.1.2 Growing R&D in Biologics and Biosimilars
3.1.1.3 Advancements in Supply Chain Technology
3.1.1.4 Increase in Comparator Sourcing
3.1.2 Market Restraint Analysis
3.1.2.1 Presence of Stringent Regulatory Policies
3.1.2.2 High Possibility of Counterfeiting Drugs
3.1.3 Penetration & Growth Prospect Mapping
3.1.4 SWOT Analysis by PESTEL
3.1.5 Industry Analysis-Porter’s
3.1.6 Clinical Trial Supplies Market: Impact of COVID-19
3.1.6.1 Supply Chain
3.1.6.2 Changing Market Trends
Chapter 4. Clinical Trial Supplies Market: Segment Analysis, By Phase, 2017 – 2030 (USD Million)
4.1 Definitions and Scope
4.2 Phase Market Share Analysis
4.3 Segment Dashboard
4.4 Clinical trial supplies Market By Phase
4.4.1 Phase I
4.4.1.1 Phase I Market Estimates and Forecast, 2017 – 2030 (In Million)
4.4.2 Phase II
4.4.2.1 Phase II Market Estimates and Forecast, 2017 – 2030 (In Million)
4.4.3 Phase III
4.4.3.1 Phase III Market Estimates and Forecast, 2017 – 2030 (In Million)
4.4.4 Others
4.4.4.1 Others Market Estimates and Forecast, 2017 – 2030 (In Million)
Chapter 5. Clinical Trial Supplies Market: Segment Analysis, By Product and Service, 2017 – 2030 (USD Million)
5.1 Definitions and Scope
5.2 Product and Service Market Share Analysis
5.3 Segment Dashboard
5.4 Clinical Trial Supplies Market by Product & Service
5.4.1 Manufacturing
5.4.1.1 Manufacturing Market Estimates and Forecast, 2017 – 2030 (In Million)
5.4.2 Storage & Distribution
5.4.2.1 Storage & Distribution Market Estimates and Forecast, 2017 – 2030 (In Million)
5.4.2.2 Cold Chain Distribution
5.4.2.3 Non-Cold Chain Distribution
5.4.3 Supply Chain Management
5.4.3.1 Supply Chain Management Market Estimates and Forecast, 2017 – 2030 (In Million)
Chapter 6. Clinical Trial Supplies Market: Segment Analysis, By End Use, 2017 – 2030 (USD Million)
6.1 Definitions and Scope
6.2 End-Use Market Share Analysis
6.3 Segment Dashboard
6.4 Clinical Trial Supplies Market by End Use
6.4.1 Pharmaceutical
6.4.1.1 Pharmaceutical Market Estimates and Forecast, 2017 – 2030 (In Million)
6.4.2 Biologics
6.4.2.1 Biologics Market Estimates and Forecast, 2017 – 2030 (In Million)
6.4.3 Medical Devices
6.4.3.1 Medical Device Market Estimates and Forecast, 2017 – 2030 (In Million)
6.4.4 Others
6.4.4.1 Others Market Estimates and Forecast, 2017 – 2030 (In Million)
Chapter 7. Clinical Trial Supplies Market: Segment Analysis, By Therapeutic Use, 2017 – 2030 (USD Million)
7.1 Definitions and Scope
7.2 Therapeutic Use Market Share Analysis
7.3 Segment Dashboard
7.4 Clinical Trial Supplies Market by Therapeutic Use
7.4.1 Oncology
7.4.1.1 Oncology Market Estimates and Forecast, 2017 – 2030 (In Million)
7.4.2 Central Nervous System (CNS) Disorders
7.4.2.1 CNS Market Estimates and Forecast, 2017 – 2030 (In Million)
7.4.3 Cardiovascular
7.4.3.1 Cardiovascular Market Estimates and Forecast, 2017 – 2030 (In Million)
7.4.4 Infectious diseases
7.4.4.1 Infectious Diseases Market Estimates and Forecast, 2017 – 2030 (In Million)
7.4.5 Metabolic disorders
7.4.5.1 Metabolic Disorders Market Estimates and Forecast, 2017 – 2030 (In Million)
7.4.6 Others
7.4.6.1 Others Market Estimates and Forecast, 2017 – 2030 (In Million)
Chapter 8. Clinical Trial Supplies Market: Regional Market Analysis, 2017 – 2030 (USD Million)
8.1 Regional Market Dashboard
8.2 Definitions and Scope
8.3 Regional Market Share Analysis
8.4 North America
8.4.1 North America Market Estimates and Forecast, 2017 – 2030
8.4.2 U.S.
8.4.2.1 U.S. Market Estimates and Forecast, 2017 – 2030
8.4.3 Canada
8.4.3.1 Canada Market Estimates and Forecast, 2017 – 2030
8.5 Europe
8.5.1 Europe Market Estimates and Forecast, 2017 – 2030
8.5.2 Germany
8.5.2.1 Germany Market Estimates and Forecast, 2017 – 2030
8.5.3 U.K.
8.5.3.1 U.K. Market Estimates and Forecast, 2017 – 2030
8.6 Asia Pacific
8.6.1 Asia Pacific Market Estimates and Forecast, 2017 – 2030
8.6.2 China
8.6.2.1 China Market Estimates and Forecast, 2017 – 2030
8.6.3 Japan
8.6.3.1 Japan Market Estimates and Forecast, 2017 – 2030
8.7 Latin America
8.7.1 Latin America Market Estimates and Forecast, 2017 – 2030
8.7.2 Brazil
8.7.2.1 Brazil Market Estimates and Forecast, 2017 – 2030
8.7.3 Mexico
8.7.3.1 Mexico Market Estimates and Forecast, 2017 – 2030
8.8 Middle East and Africa
8.8.1 Middle East & Africa Market Estimates and Forecast, 2017 – 2030
8.8.2 South Africa
8.8.2.1 South Africa Market Estimates and Forecast, 2017 – 2030
8.8.3 Saudi Arabia
8.8.3.1 Saudi Arabia Market Estimates and Forecast, 2017 – 2030
Chapter 9. Clinical Trial Supplies Market – Competitive Analysis
9.1 Company Profiles
9.1.1 Almac Group
9.1.1.1 Company Overview
9.1.1.2 Service Benchmarking
9.1.1.3 Strategic Initiatives
9.1.2 Biocair
9.1.2.1 Company Overview
9.1.2.2 Service Benchmarking
9.1.2.3 Strategic Initiatives
9.1.3 Catalent, Inc.
9.1.3.1 Company Overview
9.1.3.2 Financial Performance
9.1.3.3 Service Benchmarking
9.1.3.4 Strategic Initiatives
9.1.4 KLIFO
9.1.4.1 Company Overview
9.1.4.2 Service Benchmarking
9.1.4.3 Strategic Initiatives
9.1.5 Movianto (Walden Group)
9.1.5.1 Company Overview
9.1.5.2 Service Benchmarking
9.1.5.3 Strategic Initiatives
9.1.6 PCI Pharma Services
9.1.6.1 Company Overview
9.1.6.2 Service Benchmarking
9.1.6.3 Strategic Initiatives
9.1.7 Sharp
9.1.7.1 Company Overview
9.1.7.2 Service Benchmarking
9.1.7.3 Strategic Initiatives
9.1.8 Thermo Fischer Scientific, Inc.
9.1.8.1 Company Overview
9.1.8.2 Financial Performance
9.1.8.3 Service Benchmarking
9.1.8.4 Strategic Initiatives
9.1.9 MARKEN
9.1.9.1 Company Overview
9.1.9.2 Service Benchmarking
9.1.9.3 Strategic Initiatives
9.1.10 PAREXEL INTERNATIONAL CORPORATION
9.1.10.1 Company Overview
9.1.10.2 Financial Performance
9.1.10.3 Service Benchmarking
9.1.10.4 Strategic Initiatives
1. North America clinical trials supplies market, by clinical phases, 2017 - 2030 (USD Million)
2. North America clinical trials supplies market, by product & services, 2017 - 2030 (USD Million)
3. North America clinical trials supply chain management market, by type, 2017 - 2030 (USD Million)
4. North America clinical trials supplies market, by end use, 2017 - 2030 (USD Million)
5. North America clinical trials supplies market, by therapeutics use, 2017 - 2030 (USD Million)
6. U.S. clinical trials supplies market, by clinical phases, 2017 - 2030 (USD Million)
7. U.S. clinical trials supplies market, by product & services, 2017 - 2030 (USD Million)
8. U.S. clinical trials supply chain management market, by type, 2017 - 2030 (USD Million)
9. U.S. clinical trials supplies market, by end use, 2017 - 2030 (USD Million)
10. U.S. clinical trials supplies market, by therapeutics use, 2017 - 2030 (USD Million)
11. Canada clinical trials supplies market, by clinical phases, 2017 - 2030 (USD Million)
12. Canada clinical trials supplies market, by product & services, 2017 - 2030 (USD Million)
13. Canada clinical trials supply chain management market, by type, 2017 - 2030 (USD Million)
14. Canada clinical trials supplies market, by end use, 2017 - 2030 (USD Million)
15. Canada clinical trials supplies market, by therapeutics use, 2017 - 2030 (USD Million)
16. Europe clinical trials supplies market, by clinical phases, 2017 - 2030 (USD Million)
17. Europe clinical trials supplies market, by product & services, 2017 - 2030 (USD Million)
18. Europe clinical trials supply chain management market, by type, 2017 - 2030 (USD Million)
19. Europe clinical trials supplies market, by end use, 2017 - 2030 (USD Million)
20. Europe clinical trials supplies market, by therapeutics use, 2017 - 2030 (USD Million)
21. U.K. clinical trials supplies market, by clinical phases, 2017 - 2030 (USD Million)
22. U.K. clinical trials supplies market, by product & services, 2017 - 2030 (USD Million)
23. U.K. clinical trials supply chain management market, by type, 2017 - 2030 (USD Million)
24. U.K. clinical trials supplies market, by end use, 2017 - 2030 (USD Million)
25. U.K. clinical trials supplies market, by therapeutics use, 2017 - 2030 (USD Million)
26. Germany clinical trials supplies market, by clinical phases, 2017 - 2030 (USD Million)
27. Germany clinical trials supplies market, by product & services, 2017 - 2030 (USD Million)
28. Germany clinical trials supply chain management market, by type, 2017 - 2030 (USD Million)
29. Germany clinical trials supplies market, by end use, 2017 - 2030 (USD Million)
30. Germany clinical trials supplies market, by therapeutics use, 2017 - 2030 (USD Million)
31. Germany clinical trials supplies market, by clinical phases, 2017 - 2030 (USD Million)
32. Asia Pacific clinical trials supplies market, by product & services, 2017 - 2030 (USD Million)
33. Asia Pacific clinical trials supply chain management market, by type, 2017 - 2030 (USD Million)
34. Asia Pacific clinical trials supplies market, by end use, 2017 - 2030 (USD Million)
35. Asia Pacific clinical trials supplies market, by therapeutics use, 2017 - 2030 (USD Million)
36. Asia Pacific clinical trials supplies market, by clinical phases, 2017 - 2030 (USD Million)
37. Japan clinical trials supplies market, by product & services, 2017 - 2030 (USD Million)
38. Japan clinical trials supply chain management market, by type, 2017 - 2030 (USD Million)
39. Japan clinical trials supplies market, by end use, 2017 - 2030 (USD Million)
40. Japan clinical trials supplies market, by therapeutics use, 2017 - 2030 (USD Million)
41. China clinical trials supplies market, by product & services, 2017 - 2030 (USD Million)
42. China clinical trials supply chain management market, by type, 2017 - 2030 (USD Million)
43. China clinical trials supplies market, by end use, 2017 - 2030 (USD Million)
44. China clinical trials supplies market, by therapeutics use, 2017 - 2030 (USD Million)
45. Latin America clinical trials supplies market, by product & services, 2017 - 2030 (USD Million)
46. Latin America clinical trials supply chain management market, by type, 2017 - 2030 (USD Million)
47. Latin America clinical trials supplies market, by end use, 2017 - 2030 (USD Million)
48. Latin America clinical trials supplies market, by therapeutics use, 2017 - 2030 (USD Million)
49. Brazil clinical trials supplies market, by product & services, 2017 - 2030 (USD Million)
50. Brazil clinical trials supply chain management market, by type, 2017 - 2030 (USD Million)
51. Brazil clinical trials supplies market, by end use, 2017 - 2030 (USD Million)
52. Brazil clinical trials supplies market, by therapeutics use, 2017 - 2030 (USD Million)
53. Mexico clinical trials supplies market, by product & services, 2017 - 2030 (USD Million)
54. Mexico clinical trials supply chain management market, by type, 2017 - 2030 (USD Million)
55. Mexico clinical trials supplies market, by end use, 2017 - 2030 (USD Million)
56. Mexico clinical trials supplies market, by therapeutics use, 2017 - 2030 (USD Million)
57. MEA clinical trials supplies market, by product & services, 2017 - 2030 (USD Million)
58. MEA clinical trials supply chain management market, by type, 2017 - 2030 (USD Million)
59. MEA clinical trials supplies market, by end use, 2017 - 2030 (USD Million)
60. MEA clinical trials supplies market, by therapeutics use, 2017 - 2030 (USD Million)
61. South Africa clinical trials supplies market, by product & services, 2017 - 2030 (USD Million)
62. South Africa clinical trials supply chain management market, by type, 2017 - 2030 (USD Million)
63. South Africa clinical trials supplies market, by end use, 2017 - 2030 (USD Million)
64. South Africa clinical trials supplies market, by therapeutics use, 2017 - 2030 (USD Million)
65. Saudi Arabia clinical trials supplies market, by product & services, 2017 - 2030 (USD Million)
66. Saudi Arabia clinical trials supply chain management market, by type, 2017 - 2030 (USD Million)
67. Saudi Arabia clinical trials supplies market, by end use, 2017 - 2030 (USD Million)
68. Saudi Arabia clinical trials supplies market, by therapeutics use, 2017 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market summary (USD Million, 2016)
Fig. 8 Market trends & outlook
Fig. 9 Clinical trial supplies market: Market segmentation
Fig. 10 Clinical trial supplies market revenue (USD Million), 2017 - 2030
Fig. 11 Key Opportunities Prioritized
Fig. 12 Clinical trial supplies: Porter’s analysis
Fig. 13 Clinical trial supplies: PESTEL analysis
Fig. 14 Clinical trial supplies market phase outlook key takeaways
Fig. 15 Clinical trial supplies market: Phase movement analysis
Fig. 16 Phase I market, 2017 - 2030 (USD Million)
Fig. 17 Phase II market, 2017 - 2030 (USD Million)
Fig. 18 Phase III market, 2017 - 2030 (USD Million)
Fig. 19 Others market, 2017 - 2030 (USD Million)
Fig. 20 Clinical trial supplies market product & service outlook key takeaways
Fig. 21 Clinical trial supplies market: Product & service movement analysis
Fig. 22 Manufacturing market, 2017 - 2030 (USD Million)
Fig. 23 Storage & distribution market, 2017 - 2030 (USD Million)
Fig. 24 Cold chain-based storage & distribution market, 2017 - 2030 (USD Million)
Fig. 25 Non-cold chain-based storage & distribution market, 2017 - 2030 (USD Million)
Fig. 26 Supply chain management market, 2017 - 2030 (USD Million)
Fig. 27 Clinical trial supplies market end-use outlook key takeaways
Fig. 28 Clinical trial supplies market: End-use movement analysis
Fig. 29 Pharmaceuticals market, 2017 - 2030 (USD Million)
Fig. 30 Biologics market, 2017 - 2030 (USD Million)
Fig. 31 Medical device market, 2017 - 2030 (USD Million)
Fig. 32 Other end use market, 2017 - 2030 (USD Million)
Fig. 33 Clinical trial supplies market therapeutic use outlook key takeaways
Fig. 34 Clinical trial supplies market: Therapeutic use movement analysis
Fig. 35 Oncology market, 2017 - 2030 (USD Million)
Fig. 36 CNS market, 2017 - 2030 (USD Million)
Fig. 37 Cardiovascular market, 2017 - 2030 (USD Million)
Fig. 38 Infectious disease market, 2017 - 2030 (USD Million)
Fig. 39 Metabolic disorders market, 2017 - 2030 (USD Million)
Fig. 40 Other therapeutic use market, 2017 - 2030 (USD Million)
Fig. 41 Regional marketplace: Key takeaways
Fig. 42 North America clinical trial supplies market, 2013 – 2024 (USD Million)
Fig. 43 U.S. clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 44 Canada clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 45 Europe clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 46 U.K. clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 47 Germany clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 48 Asia Pacific clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 49 Japan clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 50 China clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 51 Latin America clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 52 Brazil clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 53 Mexico clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 54 MEA clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 55 South Africa clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 56 Saudi Arabia clinical trial supplies market, 2017 - 2030 (USD Million)